These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8964654)
1. Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydrocannabinol on murine lymphoid cells. Snella E; Pross S; Friedman H Int J Immunopharmacol; 1995 Dec; 17(12):1045-54. PubMed ID: 8964654 [TBL] [Abstract][Full Text] [Related]
2. Age related immunomodulation in murine splenocytes induced by delta-9-tetrahydrocannabinol (THC). Pross S; Nakano Y; Widen R; McHugh S; Friedman H Mech Ageing Dev; 1993 May; 68(1-3):11-26. PubMed ID: 8394485 [TBL] [Abstract][Full Text] [Related]
3. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators. Pross SH; Nakano Y; Widen R; McHugh S; Newton CA; Klein TW; Friedman H Int J Immunopharmacol; 1992 Aug; 14(6):1019-27. PubMed ID: 1330945 [TBL] [Abstract][Full Text] [Related]
4. Differential immunologic modulatory effects of tetrahydrocannabinol as a function of age. Ramarathinam L; Pross S; Plescia O; Newton C; Widen R; Friedman H Mech Ageing Dev; 1997 Jun; 96(1-3):117-26. PubMed ID: 9223115 [TBL] [Abstract][Full Text] [Related]
5. Contrasting effect of delta-9-tetrahydrocannabinol on IL-2 activity in spleen and lymph node cells of mice of different ages. Nakano Y; Pross S; Friedman H Life Sci; 1993; 52(1):41-51. PubMed ID: 8380215 [TBL] [Abstract][Full Text] [Related]
6. The role of macrophages in THC-induced alteration of the cytokine network. Newton C; Klein T; Friedman H Adv Exp Med Biol; 1998; 437():207-14. PubMed ID: 9666273 [TBL] [Abstract][Full Text] [Related]
7. Modulation of interleukin 2 activity by delta 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody. Nakano Y; Pross SH; Friedman H Proc Soc Exp Biol Med; 1992 Nov; 201(2):165-8. PubMed ID: 1329110 [TBL] [Abstract][Full Text] [Related]
8. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. Zhu LX; Sharma S; Stolina M; Gardner B; Roth MD; Tashkin DP; Dubinett SM J Immunol; 2000 Jul; 165(1):373-80. PubMed ID: 10861074 [TBL] [Abstract][Full Text] [Related]
9. Increase in cytoplasmic free calcium in murine splenocytes following stimulation with anti-CD3 antibody in the presence of delta-9-tetrahydrocannabinol. Nakano Y; Pross S; Klein T; Friedman H Int J Immunopharmacol; 1993 Apr; 15(3):423-8. PubMed ID: 8389330 [TBL] [Abstract][Full Text] [Related]
10. Enhanced suppression of blastogenic responses by weanling mouse lymphoid cells treated with tetrahydrocannabinol in vitro. Pross S; Klein T; Newton C; Friedman H Proc Soc Exp Biol Med; 1987 Oct; 186(1):17-20. PubMed ID: 2819885 [TBL] [Abstract][Full Text] [Related]
11. Age-related suppression of murine lymphoid cell blastogenesis by marijuana components. Pross SH; Klein TW; Newton C; Smith J; Widen R; Friedman H Dev Comp Immunol; 1990; 14(1):131-7. PubMed ID: 2159920 [TBL] [Abstract][Full Text] [Related]
12. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Schatz AR; Koh WS; Kaminski NE Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537 [TBL] [Abstract][Full Text] [Related]
13. Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. Kawakami Y; Klein TW; Newton C; Djeu JY; Specter S; Friedman H Int J Immunopharmacol; 1988; 10(4):485-8. PubMed ID: 2844686 [TBL] [Abstract][Full Text] [Related]
14. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses. Klein TW; Newton CA; Widen R; Friedman H J Immunopharmacol; 1985; 7(4):451-66. PubMed ID: 3003204 [TBL] [Abstract][Full Text] [Related]
15. Differential suppression of T-cell subpopulations by thc (delta-9-tetrahydrocannabinol). Pross SH; Klein TW; Newton CA; Smith J; Widen R; Friedman H Int J Immunopharmacol; 1990; 12(5):539-44. PubMed ID: 2170281 [TBL] [Abstract][Full Text] [Related]
16. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. McKallip RJ; Lombard C; Martin BR; Nagarkatti M; Nagarkatti PS J Pharmacol Exp Ther; 2002 Aug; 302(2):451-65. PubMed ID: 12130702 [TBL] [Abstract][Full Text] [Related]
17. Age-associated differences in cannabinoid-induced suppression of murine spleen, lymph node and thymus cell blastogenic responses. Pross S; Newton C; Klein TW; Friedman H Immunopharmacology; 1987 Dec; 14(3):159-68. PubMed ID: 2832349 [TBL] [Abstract][Full Text] [Related]
18. delta 9-Tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. Shivers SC; Newton C; Friedman H; Klein TW Life Sci; 1994; 54(17):1281-9. PubMed ID: 8164509 [TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of THC on adult murine lymph node and spleen cell populations stimulated with mitogen or anti-CD3 antibody. Pross SH; Nakano Y; McHugh S; Widen R; Klein TW; Friedman H Immunopharmacol Immunotoxicol; 1992; 14(3):675-87. PubMed ID: 1325494 [TBL] [Abstract][Full Text] [Related]
20. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. McKallip RJ; Nagarkatti M; Nagarkatti PS J Immunol; 2005 Mar; 174(6):3281-9. PubMed ID: 15749859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]